The FDA has finally approved to market the implantable continuous glucose monitoring system named Eversense, from Senseonics, in the United States.
The San Diego-based biotech company Crinetics Therapeutics recently raised $86 million in an IPO. Prior to the new funding, the company received $63.5 million in series B funding and will see its lead asset through phase 2.
Hypothyroidism is a condition where the thyroid gland is underactive meaning that it does not produce a sufficient amount of thyroid hormones. A common cause of hypothyroidism is Hashimoto’s thyroiditis, an autoimmune disease where the body produces antibodies which attack the thyroid.
AutoDietary has got a microphone on the back to record the food chewing sound. This information will be sent to a connected smartphone via Bluetooth. The sound will then be uploaded to the cloud database, where it would be compared with existing chewing data for varied foods.
The potential reasons behind the effect of marriage include better financial security, prompt recognition of health issues and taking right action thereby improving the overall condition of a person.
Medtronic, a medical technology company, and AI-powered personalized nutrition platform Nutrino, have entered into a partnership. The FoodPrint Report technology of Nutrino is slated to be integrated into the iPro2myLog app of Medtronic, a platform which offers continuous glucose monitor enabling users to gain critical insights into their glucose levels.
For instance, the liver becomes accumulated with fat as we age due to wrinkly nuclear membranes. The nuclear membranes become wrinkled due to the absence of a particular membrane protein called lamin. This condition leads to high risk of type 2 diabetes, cardiovascular disease and death. If lamin becomes well structured, the scientists believe that they could cure the issue wrinkling.
It was great news in the field of medicine when geneticists from University of California, Los Angeles (UCLA) created a novel technique to hunt for natural hormones that would enhance cell communication to play a major role in treating obesity, diabetes and cardiovascular diseases. Scientists discovered two hormones called "notum" and "lipocalin-5", which would aid in the fat burning process. Lipocalin-5 also enhances metabolism and absorption of dietary nutrients by reducing the risk of diabetes and obesity.
Cardiovascular diseases are more prevalent in high-income countries such as India, China and US. According to WHO reports and are the leading cause of death, where around 17.7 million people die every year.
The IVD sector in the country is chiefly characterized by 70 percent laboratories offering pathology services and 30 percent entities doling out radiology and imaging services. Though domestic players are flexing their muscles and are gearing to provide new-age diagnostic services with path-breaking innovations and strategic investments, multinational companies continue to hold sway over 60% of the domestic IVD market which is expected to grow by leaps and bounds in coming times.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.